IncFact
Company Profiles: Revenue, Growth, Competition

Umoja Biopharma Revenue, Growth & Competitor Profile

Last updated:

Company Awards

VC / Private Equity
Venture Capital / Private Equity
Big Fish
Big Fish
Brain Power (IP)
Patent/Trademark IP
 

Company Profile & Annual Report for Umoja Biopharma

Access the complete profile.

Umoja Biopharma Fast Facts

Revenue$100 - $500 million    See Exact Annual Revenue
Employees100 - 500Exact Company Size
Primary Industry325411 Medicinal & Botanical Manufacturing
Address1616 Eastlake Ave E. Suite 550
Seattle, WA 98102

Note: Revenues for privately held companies are statistical evaluations.


Umoja Biopharma's Annual Report & Profile shows critical firmographic facts:
  • What is the company's size? (Annual sales and employees)
  • What industry is the company in?
    • Umoja Biopharma is classified as operating in the Medicinal & Botanical Manufacturing industry, NAICS Code 325411.

Umoja Biopharma Annual Revenue and Growth Rate

Umoja Biopharma Revenue Est.
($ Million)
Growth Rate (%)# Employees
2023 $100 - $500 million

Details in Premium Report
2022
2021
2020
2019


1-Year Growth Rate:
3-Year Growth Rate (CAGR):
Premium Report

Note: Umoja Biopharma's revenues are gauged from an analysis of company filings.



Umoja Biopharma's Income Statement (based on Industry Averages)

Umoja Biopharma P&L$ Millions
Revenue (Sales) Umoja Biopharma Premium Report
Cost of Goods Sold
Gross Profit

Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit
 


Investor Activity

Umoja Biopharma has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date Investors Percent Raised Target Size
June 24, 2021 29 100%$210 MM
Complete list of funding rounds and total amounts in the Company Report




Trademark Applications

Trademark applications show the products and services that Umoja Biopharma is developing and marketing. Umoja Biopharma doesn't have any recent trademark applications, indicating Umoja Biopharma is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark Date
U
Manufacturing services for others in the field of pharmaceutical preparations
04/20/2022

See all trademarks and details in the Full Report.


Market Share of Umoja Biopharma's Largest Competitors

A competitive analysis shows these companies are in the same general field as Umoja Biopharma, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company HeadquartersRevenue ($ MM)
XYMOGENOrlando, FL100 
AVANTI NUTRITIONAL LABORATORIESMiami Lakes, FL37 
NUTRITION FORMULATORSMiramar, FL36 
RTPRCabot, AR33 
INTEGRATED BOTANICSFort Worth, TX29 
COSMAX NBT USAGarland, TX29 
CJB INDUSTRIESValdosta, GA28 
ALTERNATIVE LABORATORIESNaples, FL28 
S&B PHARMAAzusa, CA28 




Nearby Competitors

These companies are similar in business line and location to Umoja Biopharma. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company HeadquartersRevenue ($ MM)
JUST-EVOTEC BIOLOGICSSeattle, WA100 
IMPEL PHARMACEUTICALSSeattle, WA61 
TILRAYSeattle, WA48 
UMOJA BIOPHARMASeattle, WA32 
ZYMEWORKS BIOPHARMACEUTICALSSeattle, WA21 
APTEVO THERAPEUTICSeattle, WA11 




Future Competition: Umoja Biopharma's Fastest Growing Competitors

These companies are in the same general field as Umoja Biopharma and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

CompanyRevenue ($ MM)
Umoja Biopharma Competitors